Hydroxyurea in the Treatment of Sickle Cell Disease

Clinical trial NCT02709681 · COMPLETED

Trial details

NCT number: NCT02709681
Sponsor: Società Italiana Talassemie ed Emoglobinopatie
Status: COMPLETED
Study type: OBSERVATIONAL

Sickle Cell Disease

Start date: 2015-11-01
Primary completion: 2016-11-01
Enrollment: 628

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.